Search

Your search keyword '"Rous sarcoma virus physiology"' showing total 51 results

Search Constraints

Start Over You searched for: Descriptor "Rous sarcoma virus physiology" Remove constraint Descriptor: "Rous sarcoma virus physiology"
51 results on '"Rous sarcoma virus physiology"'

Search Results

1. Comparative analysis of retroviral Gag-host cell interactions: focus on the nuclear interactome.

2. A Structural Perspective of the Role of IP6 in Immature and Mature Retroviral Assembly.

3. Structure of the mature Rous sarcoma virus lattice reveals a role for IP6 in the formation of the capsid hexamer.

4. TNPO3-Mediated Nuclear Entry of the Rous Sarcoma Virus Gag Protein Is Independent of the Cargo-Binding Domain.

5. RNA-Binding Domains of Heterologous Viral Proteins Substituted for Basic Residues in the RSV Gag NC Domain Restore Specific Packaging of Genomic RNA.

6. Cytokine gene expression following RSV-A infection.

7. Remembering Jan Svoboda: A Personal Reflection.

8. Cytosolic aminoacyl-tRNA synthetases: Unanticipated relocations for unexpected functions.

9. Oligomerization of Retrovirus Integrases.

10. In vitro assembly of the Rous Sarcoma Virus capsid protein into hexamer tubes at physiological temperature.

11. A C-terminal "Tail" Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly.

12. Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.

13. Molecular Architecture of the Retroviral Capsid.

14. Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and Dependent on the Spacer Peptide Assembly Domain.

15. Cell Association in Rous Sarcoma Virus (RSV) Rescue and Cell Infection.

16. Role of the nucleocapsid region in HIV-1 Gag assembly as investigated by quantitative fluorescence-based microscopy.

17. Rous sarcoma virus synaptic complex capable of concerted integration is kinetically trapped by human immunodeficiency virus integrase strand transfer inhibitors.

18. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.

19. Potential role for CA-SP in nucleating retroviral capsid maturation.

20. Higher-order structure of the Rous sarcoma virus SP assembly domain.

21. Molecular events accompanying rous sarcoma virus rescue from rodent cells and the role of viral gene complementation.

22. Who is this man? Francis Peyton Rous.

23. Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

24. Rous sarcoma virus centennial in Folia Biologica.

25. Anti-neoplastic effect of avian reovirus σ C protein on Rous sarcoma virus-induced tumors in chicken.

26. Modulation of ribosomal frameshifting frequency and its effect on the replication of Rous sarcoma virus.

27. Juxtaposition of two distant, serine-arginine-rich protein-binding elements is required for optimal polyadenylation in Rous sarcoma virus.

28. Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.

29. From Rous sarcoma virus to plasminogen activator, src oncogene and cancer management.

30. Pleiotropic action of AP-1 in v-Src-transformed cells.

31. Subversion of the actin cytoskeleton during viral infection.

32. Conserved and variable features of Gag structure and arrangement in immature retrovirus particles.

33. Structural features in the Rous sarcoma virus RNA stability element are necessary for sensing the correct termination codon.

34. An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus.

35. Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study.

36. Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging.

37. Retroviral capsid assembly: a role for the CA dimer in initiation.

38. Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

39. Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase.

40. The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

41. Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.

42. Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid.

43. Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.

44. Foundations in cancer research. The turns of life and science.

45. Intermolecular interactions between retroviral Gag proteins in the nucleus.

46. Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.

47. Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.

48. Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src.

49. Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA.

50. Anti-BDCA-4 (neuropilin-1) antibody can suppress virus-induced IFN-alpha production of plasmacytoid dendritic cells.

Catalog

Books, media, physical & digital resources